X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
3-hour infusion (257) 257
oncology (227) 227
humans (218) 218
female (181) 181
paclitaxel (156) 156
middle aged (149) 149
paclitaxel - administration & dosage (143) 143
aged (134) 134
adult (130) 130
antineoplastic combined chemotherapy protocols - therapeutic use (119) 119
chemotherapy (115) 115
taxol (97) 97
paclitaxel - adverse effects (92) 92
male (91) 91
breast neoplasms - drug therapy (85) 85
antineoplastic combined chemotherapy protocols - adverse effects (74) 74
drug administration schedule (71) 71
treatment outcome (70) 70
phase-ii trial (66) 66
cisplatin (64) 64
paclitaxel - therapeutic use (60) 60
therapy (59) 59
doxorubicin (53) 53
trial (52) 52
pharmacology & pharmacy (50) 50
lung neoplasms - drug therapy (48) 48
breast neoplasms - pathology (46) 46
antineoplastic agents, phytogenic - administration & dosage (43) 43
carcinoma (43) 43
antineoplastic agents, phytogenic - therapeutic use (42) 42
carcinoma, non-small-cell lung - drug therapy (42) 42
combination (42) 42
neoplasm metastasis (42) 42
infusions, intravenous (41) 41
carboplatin (40) 40
colony-stimulating factor (40) 40
breast cancer (39) 39
cancer (39) 39
docetaxel (39) 39
dose-response relationship, drug (39) 39
metastatic breast-cancer (38) 38
stomach neoplasms - drug therapy (38) 38
antineoplastic agents, phytogenic - adverse effects (37) 37
antineoplastic combined chemotherapy protocols - administration & dosage (36) 36
survival analysis (35) 35
index medicus (33) 33
pharmacokinetics (33) 33
phase-ii (33) 33
paclitaxel - pharmacokinetics (32) 32
randomized trial (32) 32
medicine & public health (31) 31
5-fluorouracil (30) 30
neutropenia - chemically induced (29) 29
ovarian-cancer (29) 29
disease progression (28) 28
disease-free survival (28) 28
gastric cancer (27) 27
survival rate (27) 27
combination chemotherapy (26) 26
neoplasm staging (26) 26
stomach neoplasms - pathology (26) 26
carboplatin - administration & dosage (25) 25
cisplatin - administration & dosage (24) 24
cooperative-oncology-group (24) 24
fluorouracil (24) 24
maximum tolerated dose (22) 22
cell lung-cancer (20) 20
k dm oncology (20) 20
paclitaxel - analogs & derivatives (20) 20
taxoids (20) 20
adenocarcinoma - drug therapy (19) 19
aged, 80 and over (19) 19
fluorouracil - administration & dosage (19) 19
clinical trials as topic (18) 18
toxicity (18) 18
antineoplastic agents - therapeutic use (17) 17
antineoplastic agents, phytogenic - pharmacokinetics (17) 17
drug resistance, neoplasm (17) 17
follow-up studies (17) 17
paclitaxel - pharmacology (17) 17
s-1 (17) 17
women (17) 17
antineoplastic combined chemotherapy protocols - pharmacokinetics (16) 16
epirubicin (16) 16
gemcitabine (16) 16
neoplasm recurrence, local - drug therapy (16) 16
supportive care (16) 16
animals (15) 15
chemotherapy, adjuvant (15) 15
drug combinations (15) 15
epirubicin - administration & dosage (15) 15
analysis (14) 14
breast neoplasms - mortality (14) 14
carboplatin - adverse effects (14) 14
care and treatment (14) 14
doxorubicin - administration & dosage (14) 14
metastatic breast cancer (14) 14
mice (14) 14
pharmacology/toxicology (14) 14
phase-i (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thyroid, ISSN 1050-7256, 2000, Volume 10, Issue 7, pp. 587 - 594
Anaplastic thyroid carcinoma is a rare, lethal disease with no effective systemic therapies. Preclinical studies demonstrated antineoplastic activity of... 
BREAST-CANCER | NONSMALL CELL LUNG | P53 GENE | PHARMACOKINETICS | TAXOL | 96-HOUR INFUSION | ENDOCRINOLOGY & METABOLISM | OVARIAN-CANCER | 3-HOUR | LINES | RADIATION-THERAPY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/1999, Volume 17, Issue 5, pp. 1413 - 1424
Purpose: This phase III study compared docetaxel with mitomycin plus vinblastine (MV) in patients with metastatic breast cancer (MBC) progressing despite... 
THERAPY | ONCOLOGY | DISEASE | PHASE-II | QLQ-C30 | 3-HOUR INFUSION | PACLITAXEL
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article